Biolinerx Ltd.-Spons ADRBLRX
13F holders, Q3 2025 (September 30)14holders −3
3new positions
6sold out
1famous investor
$3.77avg. 13F price*
At the end of Q3 2025, 14 institutions reported holding Biolinerx Ltd.-Spons ADR (BLRX) in their 13F filings, down 3 from Q2 2025. 3 opened new positions and 6 sold out. The largest holders were Citadel Advisors ($38K), UBS Group AG ($24K) and Morgan Stanley ($23K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Biolinerx Ltd.-Spons ADR
- CUSIP
- 09071M304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $24K |
| Exits | 6 | $134K |
All 13F filers, Q2 2025 → Q3 2025: 10,848 shares bought and 49,364 shares sold, net −38,516 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Citadel Advisors | 0.00% | Reduce -33.0% | 10,020 | $38K |
| UBS Group AG | 0.00% | New | 6,387 | $24K |
| Morgan Stanley | 0.00% | Add +285.8% | 5,953 | $23K |
| Rhumbline Advisers | 0.00% | Reduce -28.2% | 3,070 | $12K |
| Wells Fargo & Company | 0.00% | No change | 1,750 | $7K |
| Nemes Rush Group LLC | 0.00% | No change | 250 | $945 |
| NewEdge Advisors, LLC | 0.00% | No change | 107 | $405 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 39 | $147 |
| Rockefeller Capital Management L.P. | 0.00% | New | 12 | $45 |
| Bank of America Corp. | 0.00% | No change | 2 | $8 |
| Danske Bank A/S | 0.00% | No change | 2 | $8 |
| SBI Securities Co., Ltd. | 0.00% | No change | 2 | $8 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $3 |
| Simplex Trading, LLC | 0.00% | Reduce -99.3% | 105 | $0 |
"% of holder's portfolio" is BLRX's weight in each manager's 13F, not the share of Biolinerx Ltd.-Spons ADR the manager owns.